SIRT5 knockdown suppresses HCC cell proliferation and SIRT5 overexpression promotes HCC cell proliferation, and downregulation of SIRT5 has been proposed as a drug target for HCC therapies41. The gene discussed is SIRT5; the disease is hepatocellular carcinoma.